• 제목/요약/키워드: Glucose transporter 4 mRNA

검색결과 34건 처리시간 0.033초

HepG2 세포에서 아마란스 종자 에탄올 추출물이 포도당 흡수 조절에 미치는 효과 (Effect of amaranth seed extracts on glycemic control in HepG2 cells)

  • 박소진;박종군;황은희
    • Journal of Nutrition and Health
    • /
    • 제54권6호
    • /
    • pp.603-617
    • /
    • 2021
  • 혈당 조절에 유익한 천연 식품을 발굴하고 그 효과를 밝혀보고자 본 연구에서는 아마란스 종자에 주목하여 몇 가지 혈당조절 연관 지표의 증감 정도를 알아보았다. 아마란스 종자의 색과 발아 여부에 따라 효능에 차이가 있는지 알아보기 위하여 발아 흑색 아마란스는 germinated black amaranth (GBA), 비발아 흑색 아마란스는 black amaranth (BA), 발아 황색 아마란스는 germinated yellow amaranth (GYA), 비발아 황색 아마란스는 yellow amaranth (YA)로 구분하였고 각각의 시료는 80% 에탄올 추출물을 만들어 사용하였다. 본 연구에서 α-amylase 및 α-glucosidase 저해 활성을 측정한 결과 GBA, BA, GYA, YA 순으로 높은 저해 활성을 나타냈으며 특히 α-amylase 저해 활성 실험에서 GBA는 양성 대조물질인 acarbose와 거의 비슷한 수준을 나타내어 높은 저해 활성을 가지는 것으로 판단된다. HepG2 세포에서 포도당 흡수를 측정한 결과 모든 추출물에서 농도 의존적으로 증가하였고 GBA > BA > GYA > YA 순으로 높게 나타났다. 특히 50 ㎍/mL 농도에서 GBA는 인슐린과 유사한 값을 나타내었다. GBA를 농도별로 처리한 HepG2 세포에서 ACC, GLUT-2, GLUT-4, IRS-1, IRS-2 mRNA 발현 정도는 모두 농도 의존적으로 증가하였다. 이상의 결과로 아마란스 종자는 혈당 조절 및 개선에 효능이 있다고 평가되며 특히 발아한 흑색 종자가 혈당 조절 효능이 높게 나타남을 보여 혈당 조절에 유익한 효능을 가지는 식품 소재가 될 수 있음을 확인하였다.

Far-infrared rays enhance mitochondrial biogenesis and GLUT3 expression under low glucose conditions in rat skeletal muscle cells

  • Seo, Yelim;Kim, Young-Won;Lee, Donghee;Kim, Donghyeon;Kim, Kyoungseo;Kim, Taewoo;Baek, Changyeob;Lee, Yerim;Lee, Junhyeok;Lee, Hosung;Jang, Geonwoo;Jeong, Wonyeong;Choi, Junho;Hwang, Doegeun;Suh, Jung Soo;Kim, Sun-Woo;Kim, Hyoung Kyu;Han, Jin;Bang, Hyoweon;Kim, Jung-Ha;Zhou, Tong;Ko, Jae-Hong
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제25권2호
    • /
    • pp.167-175
    • /
    • 2021
  • Far-infrared rays (FIR) are known to have various effects on atoms and molecular structures within cells owing to their radiation and vibration frequencies. The present study examined the effects of FIR on gene expression related to glucose transport through microarray analysis in rat skeletal muscle cells, as well as on mitochondrial biogenesis, at high and low glucose conditions. FIR were emitted from a bio-active material coated fabric (BMCF). L6 cells were treated with 30% BMCF for 24 h in medium containing 25 or 5.5 mM glucose, and changes in the expression of glucose transporter genes were determined. The expression of GLUT3 (Slc2a3) increased 2.0-fold (p < 0.05) under 5.5 mM glucose and 30% BMCF. In addition, mitochondrial oxygen consumption and membrane potential (ΔΨm) increased 1.5- and 3.4-fold (p < 0.05 and p < 0.001), respectively, but no significant change in expression of Pgc-1a, a regulator of mitochondrial biogenesis, was observed in 24 h. To analyze the relationship between GLUT3 expression and mitochondrial biogenesis under FIR, GLUT3 was down-modulated by siRNA for 72 h. As a result, the ΔΨm of the GLUT3 siRNA-treated cells increased 3.0-fold (p < 0.001), whereas that of the control group increased 4.6-fold (p < 0.001). Moreover, Pgc-1a expression increased upon 30% BMCF treatment for 72 h; an effect that was more pronounced in the presence of GLUT3. These results suggest that FIR may hold therapeutic potential for improving glucose metabolism and mitochondrial function in metabolic diseases associated with insufficient glucose supply, such as type 2 diabetes.

1-Deoxynojirimycin Isolated from a Bacillus subtilis Stimulates Adiponectin and GLUT4 Expressions in 3T3-L1 Adipocytes

  • Lee, Seung-Min;Do, Hyun Ju;Shin, Min-Jeong;Seong, Su-Il;Hwang, Kyo Yeol;Lee, Jae Yeon;Kwon, Ohsuk;Jin, Taewon;Chung, Ji Hyung
    • Journal of Microbiology and Biotechnology
    • /
    • 제23권5호
    • /
    • pp.637-643
    • /
    • 2013
  • We have demonstrated that 1-deoxynojirimycin (DNJ) isolated from Bacillus subtilis MORI could enhance the levels of adiponectin and its receptors in differentiated 3T3-L1 adipocytes, which has been shown to be effective in lowering blood glucose levels and enhancing insulin sensitivity. DNJ was not toxic to differentiated 3T3-L1 adipocytes for up to a concentration of $5{\mu}M$. In terms of expression levels of adiponectin and its receptors (AdipoR1 and AdipoR2), DNJ in concentrations as low as $0.5{\mu}M$ elevated both mRNA and protein levels of adiponectin and transcript levels of AdipoR1 and AdipoR2. In addition, DNJ increased phosphorylation of 5' adenosine monophosphate-activated protein kinase (AMPK) in a statistically significant manner. Finally, treatment with DNJ resulted in increased mRNA expression of glucose transporter 4 (GLUT4), which encodes for a glucose transporter, along with a significant increase in glucose uptake into the adipocytes based on results of a 2-deoxy-D-[$^3H$] glucose uptake assay. Our findings indicate that DNJ may greatly facilitate glucose uptake into adipose tissues by increasing the action of adiponectin via its up-regulated expression as well as its receptor genes. In addition, the glucose-lowering effects of DNJ may be achieved by an increased abundance of GLUT4 protein in the plasma membrane, as a consequence of the increased transcript levels of the GLUT4 gene and the activation of AMPK.

Chicken serum uric acid level is regulated by glucose transporter 9

  • Ding, Xuedong;Peng, Chenglu;Li, Siting;Li, Manman;Li, Xinlu;Wang, Zhi;Li, Yu;Wang, Xichun;Li, Jinchun;Wu, Jinjie
    • Animal Bioscience
    • /
    • 제34권4호
    • /
    • pp.670-679
    • /
    • 2021
  • Objective: Glucose transporter 9 (GLUT9) is a uric acid transporter that is associated with uric absorption in mice and humans; but it is unknown whether GLUT9 involves in chicken uric acid regulation. This experiment aimed to investigate the chicken GLUT9 expression and serum uric acid (SUA) level. Methods: Sixty chickens were divided into 4 groups (n = 15): a control group (NC); a sulfonamide-treated group (SD) supplemented with sulfamonomethoxine sodium via drinking water (8 mg/L); a fishmeal group (FM) supplemented with 16% fishmeal in diet; and a uric acid-injection group (IU), where uric acid (250 mg/kg) was intraperitoneally injected once a day. The serum was collected weekly to detect the SUA level. Liver, kidney, jejunum, and ileum tissues were collected to detect the GLUT9 mRNA and protein expression. Results: The results showed in the SD and IU groups, the SUA level increased and GLUT9 expression increased in the liver, but decreased in the kidney, jejunum, and ileum. In the FM group, the SUA level decreased slightly and GLUT9 expression increased in the kidney, but decreased in the liver, jejunum, and ileum. Correlation analysis revealed that liver GLUT9 expression correlated positively, and renal GLUT9 expression correlated negatively with the SUA level. Conclusion: These results demonstrate that there may be a feedback regulation of GLUT9 in the chicken liver and kidney to maintain the SUA balance; however, the underlying mechanism needs to be investigated in future studies.

한우 Glucose Transporter 4 유전자의 분자생물학적 해석 (Molecular Characterization of Hanwoo Glucose Transporter 4 Gene)

  • 이상미;정영희;김혜민;박효영;윤두학;문승주;정의룡;강만종
    • Journal of Animal Science and Technology
    • /
    • 제47권6호
    • /
    • pp.1087-1094
    • /
    • 2005
  • 세포 생장과 대사에 있어서 glucose의 세포내 도입은 대부분 동물세포에 필수적이며 이와 같은 도입은 glucose transport protein에 의하여 수행된다. glucose transport protein 중에 GLUT4는 사람과 설치류의 지방조직과 골격근에 있어서 인슐린 자극에 의하여 glucose을 세포내로 도입하는 중요한 역할을 수행한다. 본 연구에서는 한우로부터 이와 같은 GLUT4 유전자를 동정하고 그 발현을 조사하였다. 한우 GLUT4 유전자는 1527bp의 open reading frame으로 구성되어 있으며 509개의 아미노산을 암호화하고 있었다. 그리고 한우 GLUT4 아미노산을 홀스타인, 사람, 생쥐와 비교한 결과 매우 높은 상동성을 나타내었다. 한우 각 조직에 있어서 GLUT4 mRNA의 발현을 확인한 결과 심장에서 가장 높은 발현을 나타내었으며 갈비, 등심, 대장에서는 낮은 발현을 보였다. 그리고 피하지방과 소장지방에서 GLUT4의 발현을 확인하기 위하여 RT-PCR을 수행한 결과 지방조직에서도 발현을 확인할 수 있었다. 한우 intramuscular preadipocyte 세포가 지방세포로 분화하는 과정에 있어서 GLUT4의 발현을 RT-PCR로 확인한 결과 분화에 따라 점차 줄어드는 경향을 나타내었다. 이와 같은 결과는 한우 지방조직에서의 GLUT4 기능은 사람과 생쥐에서의 기능과 다르다는 것을 나타낸다.

Insulin sensitivity improvement of fermented Korean Red Ginseng (Panax ginseng) mediated by insulin resistance hallmarks in old-aged ob/ob mice

  • Cheon, Jeong-Mu;Kim, Dae-Ik;Kim, Kil-Soo
    • Journal of Ginseng Research
    • /
    • 제39권4호
    • /
    • pp.331-337
    • /
    • 2015
  • Background: The biological actions of various ginseng extracts have been studied for treating obesity and diabetes mellitus. However, few studies have evaluated the effects of fermented Korean Red Ginseng (Panax ginseng Meyer) on metabolic syndrome. The present study evaluated the antiobesity and antidiabetic effects of fermented red ginseng (FRG) on old-aged, obese, leptin-deficient (B6.V-Lepob, "ob/ob") mice. Methods: The animals were divided into three groups and given water containing 0%, 0.5%, and 1.0% FRG for 16 wk. The effect of FRG on ob/ob mice was determined by measuring changes in body weight, levels of blood glucose, serum contents of triglycerides, total cholesterol and free fatty acids, messenger RNA (mRNA) expressions of key factors associated with insulin action, such as insulin receptor (IR), lipoprotein lipase (LPL), glucose transporter 1 and 4 (GLUT1 and GLUT4), peroxisome proliferators-activated receptor gamma ($PPAR-{\gamma}$), and phosphoenolpyruvate carboxykinase (PEPCK) in the liver and in muscle, and histology of the liver and pancreas. Results: FRG-treated mice had decreased body weight and blood glucose levels compared with control ob/ob mice. However, anti-obesity effect of FRG was not evident rather than hypoglycemic effect in old aged ob/ob mice. The hyperlipidemia in control group was attenuated in FRG-treated ob/ob mice. The mRNA expressions of IR, LPL, GLUT1, GLUT4, $PPAR-{\gamma}$, and PEPCK in the liver and in muscle were increased in the FRG-treated groups compared with the control group. Conclusion: These results suggest that FRG may play a vital role in improving insulin sensitivity relative to reducing body weight in old-aged ob/ob mice.

Glycolytic and oxidative muscles under acute glucose supplementation differ in their metabolic responses to fatty acyl-CoA synthetase gene suppression

  • Jung, Yun Hee;Bu, So Young
    • Journal of Nutrition and Health
    • /
    • 제55권1호
    • /
    • pp.70-84
    • /
    • 2022
  • Purpose: Skeletal muscles display significant heterogeneity in metabolic responses, owing to the composition of metabolically distinct fiber types. Recently, numerous studies have reported that in skeletal muscles, suppression of genes related to fatty acid channeling alters the triacylglycerol (TAG) synthesis and switches the energy substrates. However, such responses may differ, depending on the type of muscle fiber. Hence, we conducted in vitro and animal studies to compare the metabolic responses of different types of skeletal muscle fibers to the deficiency of fatty acyl-CoA synthetase (Acsl)6, one of the main fatty acid-activating enzymes. Methods: Differentiated skeletal myotubes were transfected with selected Acsl6 short interfering RNA (siRNA), and C57BL/6J mice were subjected to siRNA to induce Acsl6 deficiency. TAG accumulation and expression levels of insulin signaling proteins in response to acute glucose supplementation were measured in immortalized cell-based skeletal myotubes, oxidative muscles (OM), and glycolytic muscles (GM) derived from the animals. Results: Under conditions of high glucose supplementation, suppression of the Acsl6 gene resulted in decreased TAG and glycogen synthesis in the C2C12 skeletal myotubes. The expression of Glut4, a glucose transporter, was similarly downregulated. In the animal study, the level of TAG accumulation in OM was higher than levels determined in GM. However, a similar decrease in TAG accumulation was obtained in the two muscle types in response to Acsl6 suppression. Moreover, Acsl6 suppression enhanced the phosphorylation of insulin signaling proteins (Foxo-1, mTORc-1) only in GM, while no such changes were observed in OM. In addition, the induction ratio of phosphorylated proteins in response to glucose or Acsl6 suppression was significantly higher in GM than in OM. Conclusion: The results of this study demonstrate that Acsl6 differentially regulates the energy metabolism of skeletal muscles in response to glucose supplementation, thereby indicating that the fiber type or fiber composition of mixed muscles may skew the results of metabolic studies.

사람 암세포와 단핵세포에서 고포도당 농도에 의한 FDG 섭취 저하의 서로 다른 기전 (Decreased glucose uptake by hyperglycemia is regulated by different mechanisms in human cancer cells and monocytes)

  • 김채균;정준기;이용진;홍미경;정재민;이동수;이명철
    • 대한핵의학회지
    • /
    • 제36권2호
    • /
    • pp.110-120
    • /
    • 2002
  • 목적: FDG PET은 악성종양의 진단에 유용하게 쓰이고 있으나, 염증에도 섭취되어 진단에 어려움이 있다. 염증에서 F-18-FDG 섭취는 단핵세포에서 포도당대사가 항진되어 나타난다. 이 연구에서는 사람의 암세포와 단핵세포간에 포도당대사에 차이가 있는지 알아보고자 하였다. 대상 및 방법: 사람의 대장암 세포주(SNU-C2A, SNU-C4, SNU-C5)와 폐암 세포주(NCI-H522), 단핵세포를 포도당 농도가 다른 배지에서 각각 배양시키고, FDG 섭취와 포도당운반체 1(Glut1)의 발현, hexokinase 활성도의 변화를 비교 분석하였다. 결과: 포도당이 없는 배지에서는 암세포와 단핵세포 모두에서 FDG 섭취가 증가되나 포도당 고농도(16.7 mM)에서는 섭취가 감소하였다. 이 고농도에서 Glut1 mRNA의 발현은 대장암 세포주, 폐암 세포주에서 감소하였다. 고농도의 포도당 배지에서 Glut1 단백질의 발현도 4종류의 암세포에서 모두 감소하였으나, 단핵세포에서는 변화가 없었다. SNU-C2A, SNU-C4, NCI-H522 세포에서 hexokinase의 활성도는 비슷하였고, 단핵세포와 SNU-C5에서는 약간 증가하였다. 결론: 포도당 섭취에 있어서 사람의 암 세포주와 단핵세포는 서로 다른 기전을 보이고 있다. 대장암 세포는 포도당 농도에 의한 포도당 섭취 변화가 Glut1에 의하여 조절되나, 단핵세포는 다른 기전을 가지고 있다.

진피(陳皮)의 항산화 활성 및 L6 근육세포에서 당대사에 미치는 영향 (Antioxidant Activity of Citrus Peel and Effect on its Glucose Metabolism in L6 Rat Skeletal Muscle Cells)

  • 김수현;박해진;김경조;김민주;이진아;이아름;노성수
    • 대한본초학회지
    • /
    • 제33권4호
    • /
    • pp.101-108
    • /
    • 2018
  • Objectives : This study aimed to effects antioxidant activity of citrus peel extract (CPE) and effect on its glucose metabolism in L6 rat skeletal muscle cells. Methods : Antioxidative activities were evaluated by using 10 kinds of natural materials, and total polyphenol and flavonoid contents were examined. The L6 muscle cells toxicity of CPE was examined by MTT assay. Expression of glucose-related genes in L6 muscle cells by CPE treatment was analyzed by real-time PCR and western blotting. Results : The $IC_{50}$ values of DPPH and ABTS free radical scavenging activity of CPE were ($15.47{\pm}0.26{\mu}g/m{\ell}$ and $12.07{\pm}1.23{\mu}g/m{\ell}$, respectively), effectively clearing DPPH and ABTS. CPE showed total polyphenol and flavonoid contents ($20.30{\pm}0.38$ and $64.20{\pm}0.52$, respectively). The selected CPE were used in experiments using an effective concentration that is not toxic in L6 muscle cells. We investigated insulin receptor substrate-1 (IRS-1), phosphatidylinositol 3-kinase regulatory (PI3KR), Akt, and glucose transporter 4 (GLUT4). mRNA analysis by realtime PCR showed no significant difference, but CPE-treated cells showed a tendency to increase in concentration-dependent manner. However, analysis of protein expression of Akt and GLUT4 by western blotting showed that CPE treatment significantly increased concentration dependent (p<0.001). Conclusions : As a result, citrus peel extract with high antioxidant activity regulates glucose metabolism in L6 muscle cells. Therefore, CPE can be a potential treatment for the treatment of diabetes.

Cloning and Distribution of Facilitative Glucose Transporter 2 (SLC2A2) in Pigs

  • Zuo, Jianjun;Huang, Zhiyi;Zhi, Aimin;Zou, Shigeng;Zhou, Xiangyan;Dai, Fawen;Ye, Hui;Feng, Dingyuan
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제23권9호
    • /
    • pp.1159-1165
    • /
    • 2010
  • Glucose is the main energy source for mammalian cells and its absorption is co-mediated by two different families of glucose transporters, sodium/glucose co-transporters (SGLTs) and facilitative glucose transporters (GLUTs). Here, we report the cloning and tissue distribution of porcine GLUT2. The GLUT2 was cloned by RACE and its cDNA was 2,051 bp long (GenBank accession no. EF140874). An AAATAA consensus sequence at nucleotide positions 1936-1941 was located upstream of the poly $(A)^+$ tail. Open reading frame analysis suggested that porcine GLUT2 contained 524 amino acids, with molecular weight of 57 kDa. The amino acid sequence of porcine GLUT2 was 87% and 79.4% identical with human and mouse GLUT2, respectively. GLUT2 mRNA was detected at highest level in porcine liver, at moderate levels in the small intestine and kidney, and at low levels in the brain, lung, muscle and heart. In the small intestine, the highest level was in the jejunum. In conclusion, the mRNA expression of GLUT2 was not only differentially regulated by age, but also differentially distributed along the small intestine of piglets, which may be related to availability of different intestinal luminal substrate concentrations resulting from different food sources and digestibility.